Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009


Medical Procedures and Risk for Sporadic Creutzfeldt-Jakob Disease, Japan, 1999–2008

Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, and Masahito YamadaComments to Author 
Author affiliations: Kanazawa University Graduate School of Medical Science, Kanazawa, Japan (T. Hamaguchi, M. Noguchi-Shinohara, I. Nozaki, M. Yamada); Jichi Medical University, Shimotsuke, Japan (Y. Nakamura); Kohnodai Hospital, Ichikawa, Japan (T. Sato); Tohoku University Graduate School of Medicine, Sendai, Japan (T. Kitamoto); Tokyo Medical and Dental University, Tokyo, Japan (H. Mizusawa); Creutzfeldt-Jakob Disease Surveillance Committee, Japan (Y. Nakamura, T. Sato, J. Mizusawa, T. Kitamoto, M. Yamada)

Main Article

Table 7

Data for sCJD patients who had ophthalmic surgery for cataracts after onset of sCJD symptoms, Japan, 1999–2008*

Patient no. Interval between onset of sCJD symptoms and surgery, mo Age at onset of sCJD, y Symptom at onset of sCJD
1 0 60 Gait disturbance
2 0 61 Dementia
3 0 63 Visual impairment
4 0 71 Visual impairment
5 0 74 Visual impairment
6 0 74 Visual impairment
7 1 66 Dementia
8 1 74 Depression
9 1 85 Visual impairment
10 2 79 Tremor
11 4 81 Visual impairment
12 8 77 Anxiety
13 10 57 Dementia
14 14 64 Visual impairment

*sCJD, sporadic Creutzfeldt-Jakob disease.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO